J2 Capital Management Inc

Position in LLY — ELI LILLY & Co

CIK 1586882 TROY, MI

Position in LLY

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$988,330

+$216,643 QoQ

Shares Held

824

-1.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.20%

of 13F equity value

Holder Rank

#3,155

of 4,604 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

J2 Capital Management Inc holds $5,355,034 across 6 Drug Manufacturers - General names. LLY ranks #2 (18.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	7,224	$1,817,847
2	LLY	ELI LILLY & Co This page	824	$988,330
3	MRK	Merck & Co., Inc.	6,147	$789,889
4	JNJ	Johnson & Johnson	2,765	$702,227
5	GSK	GSK plc	11,338	$594,337
6	GILD	Gilead Sciences, Inc.	3,660	$462,404

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$988,330	824	-1.8%	Shares	Sole	2026-07-20
2026-03-31	$771,687	839	+20.4%	Shares	Sole	2026-04-21
2025-12-31	$749,052	697	-3.3%	Shares	Sole	2026-01-20
2025-09-30	$550,123	721	-0.1%	Shares	Sole	2025-10-14
2025-06-30	$562,820	722	+53.9%	Shares	Sole	2025-07-21
2025-03-31	$387,351	469	+1.5%	Shares	Sole	2025-04-08
2024-12-31	$356,664	462	-32.7%	Shares	Sole	2025-01-15
2023-09-30	$368,471	686	+3.8%	Shares	Sole	2023-10-11
2023-06-30	$309,995	661	-11.7%	Shares	Sole	2023-07-17
2023-03-31	$257,221	749	+4.5%	Shares	Sole	2023-04-18
2022-12-31	$262,307	717	-38.5%	Shares	Sole	2023-01-17
2022-09-30	$377,026	1,166	-0.9%	Shares	Sole	2022-10-17
2022-06-30	$381,294	1,176	-15.8%	Shares	Sole	2022-07-19
2022-03-31	$400,058	1,397	+1.8%	Shares	Sole	2022-04-21
2021-12-31	$378,973	1,372	—	Shares	Sole	2022-01-21
No filing history on record for this holder in this stock.